In coronary artery disease (CAD), higher circulating Gal-1 levels correlated with increased fibrosis markers and vascular stiffening, with a median serum concentration of 56.3 ng/mL in patients with severe CAD compared to 32.1 ng/mL in controls (p < 0.01) [24]. Here, LGALS1 is linked to coronary artery disorder.